[1]
R. G. Makwana, K. V. Desai, V. Kikani, and M. D. Vaja, “Regulatory advances and prospects of variation filing for the registered parenteral products in USA and Europe”, Int J Drug Reg Affairs, vol. 9, no. 2, pp. 52-65, Jun. 2021.